Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD

CAMBRIDGE, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced...

Drugs.com - Clinical Trials

Fri Oct 04, 2019 07:10

Athira Pharma Announces Completion of Phase 1b Clinical Trial of NDX-1017 in Alzheimer’s Patients

SEATTLE, Oct. 2, 2019 -- Athira Pharma, Inc., a clinical-stage company dedicated to developing first-in-class therapies for Alzheimer’s and Parkinson’s disease that are focused on regeneration, today announced the completion of the Phase...

Drugs.com - Clinical Trials

Wed Oct 02, 2019 07:10

CytoDyn Announces FDA Clearance to Proceed with Phase 2 Clinical Trial of Leronlimab (PRO 140) for Treatment of NASH

VANCOUVER, Washington, Oct. 01, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential...

Drugs.com - Clinical Trials

Tue Oct 01, 2019 07:10

Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for Patients with Lupus Nephritis

LA JOLLA, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory...

Drugs.com - Clinical Trials

Tue Oct 01, 2019 07:10